Concepedia

Mauro Delorenzi

MD

167

Publications

38K

Citations

81

H-Index

1988

Active since

Affiliations

SIB Swiss Institute of Bioinformatics(Current)

University of Lausanne

Ludwig Cancer Research

École Polytechnique Fédérale de Lausanne

University Hospital of Lausanne

Mauro Delorenzi is an author at SIB Swiss Institute of Bioinformatics specializing in medicine, pathology, and cancer research.

ORCID

Top concepts

Publications per year

1988–2023

167

Publications

167

The consensus molecular subtypes of colorectal cancer

Justin Guinney, Rodrigo Dienstmann, Xin Wang et al. · Nature Medicine · 2015 · 5K citations · Full text

, , +4

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

Wendy De Roock, Bart Claes, David Bernasconi et al. · The Lancet Oncology · 2010 · 2.1K citations

, , +5

Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis

Christos Sotiriou, Pratyaksha Wirapati, Sherene Loi et al. · JNCI Journal of the National Cancer Institute · 2006 · 2.1K citations · Full text

, , +20

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

Fátima Cardoso, Laura J. van’t Veer, Jan Bogaerts et al. · New England Journal of Medicine · 2016 · 2K citations · Full text

Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer

Marc Buyse, Sherene Loi, Laura van’t Veer et al. · JNCI Journal of the National Cancer Institute · 2006 · 1.2K citations · Full text

Rows per page

1–5 of 167